Mental Health News and Research

Latest Mental Health News and Research

Viewpoints: Solving the doctor shortage; Can Gov. Scott convince Fla. lawmakers to accept Medicaid expansion?

With every new report about the recent slowdown in health-care spending there is speculation in the media that the problem of rising health costs has somehow been solved or cut down to size.

23 Apr 2013

Eating mushrooms can help increase, maintain vitamin D levels, find BUSM researchers

Researchers from Boston University School of Medicine have discovered that eating mushrooms containing Vitamin D2 can be as effective at increasing and maintaining vitamin D levels (25-hydroxyvitamin D) as taking supplemental vitamin D2 or vitamin D3.

23 Apr 2013

State roundup: Calif. lawmakers push for health plan for immigrants in U.S. illegally

A selection of health policy stories from Massachusetts, California, Michigan, Texas, the District of Columbia, Pennsylvania, South Carolina and Tennessee.

23 Apr 2013

New report presents recommendations to implement public health-based approach to drug policy

A comprehensive new report, Blueprint for a Public Health and Safety Approach to Drug Policy, by The New York Academy of Medicine and the Drug Policy Alliance presents wide-ranging recommendations to implement a public health-based approach to drug policy, calling for strong, effective leadership to make change.

23 Apr 2013

Alkermes reports topline results from phase 2 study of ALKS 5461 drug for major depressive disorder

Alkermes plc (NASDAQ: ALKS) today announced positive preliminary topline results from a phase 2 study of ALKS 5461, its novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression.

22 Apr 2013

Cerecor obtains exclusive, worldwide rights to NR2B receptor antagonist from Merck

Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside the United States and Canada, to develop and commercialize MK-0657, a small molecule NMDA receptor subunit 2B (NR2B) antagonist for all human indications, including depression.

22 Apr 2013

First Edition: April 22, 2013

Today's headlines include reports ranging from how state leaders are dealing with the consequences of rejecting the health law's Medicaid expansion to how pending immigration reform proposals could ease the nation's physician shortage.

22 Apr 2013

Advanced microscope reveals process where mutations lead to autism and other diseases

Using spinning disk microscopy on barely day-old zebra fish embryos, University of Oregon scientists have gained a new window on how synapse-building components move to worksites in the central nervous system.

22 Apr 2013

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

MR-guided focused ultrasound is a new technique that involves focusing 1024 beams of ultrasound through the skull to a focal point in the brain, very much like using the sun and a magnifying glass to burn a hole in a sheet of paper.

22 Apr 2013

Study: Stem cell transplant heals neurological deficits in mice

For the first time, human embryonic stem cells have been transformed into nerve cells that helped mice regain the ability to learn and remember.

22 Apr 2013

Sleep related breathing disorders associated with cognitive and behavioral impairment in children

People lobbying for gun control may want to consider another culprit in the post-Newtown search for the answer to our unfathomable questions.

22 Apr 2013

Study examines link between cognitive complaints and neuropsychological testing abnormalities in breast cancer patients

For many years, breast cancer patients have reported experiencing difficulties with memory, concentration and other cognitive functions following cancer treatment. Whether this mental "fogginess" is psychosomatic or reflects underlying changes in brain function has been a bone of contention among scientists and physicians.

20 Apr 2013

Viewpoints: A plan for cheaper, better care; The Philly abortion trial raises questions about regulations

The four of us came together to change the conversation around how to improve health care and constrain cost growth. What we learned is that, until better care is prioritized over more care, our nation will continue to face a problem with health-care costs.

20 Apr 2013

Senate approves mental health amendment to 'effectively derailed' gun bill

The amendment, which was added to the gun control bill a day after the broader measure that included background checks on gun purchases was rejected by the Senate, would expand a range of mental health programs.

20 Apr 2013

Research shows early access to cognitive behavioural therapy can reduce risk of psychosis

Young people seeking help who are at high risk of developing psychosis could significantly reduce their chances of going on to develop a full-blown psychotic illness by getting early access to cognitive behavioural therapy, new research shows.

From The University of Manchester 19 Apr 2013

Researchers examine health promotion and obesity prevention initiatives

More than 12 percent of preschoolers are obese, which means they have a body mass index above the 95th percentile. Among Black and Hispanic children, the figure rises to 16 percent.

19 Apr 2013

First Edition: April 19, 2013

Today's headlines include reports about a new plan by the Bipartisan Policy Center to reduce health spending released.

19 Apr 2013

Targacept moving forward with Phase 2b study of TC-5619 for treatment of schizophrenia

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it has completed recruitment of patients in the Phase 2b study of TC-5619 as a treatment for negative symptoms and cognitive dysfunction in schizophrenia.

19 Apr 2013

Excess glutamate drives schizophrenia in high-risk individuals

An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia, reports a study from investigators at Columbia University Medical Center published in the current issue of Neuron.

19 Apr 2013

Longer looks: The timely trauma response in Boston; Problems with aging doctors; Transplants from donors with HIV

The bombs at the Boston Marathon were designed to maim and kill, and they did. Three people died within the first moments of the blast. More than a hundred and seventy people were injured. They had their limbs blown off, vital arteries severed, bones fractured, flesh torn open by shrapnel or scorched by the blasts' heat. Yet it now appears that every one of the wounded alive when rescuers reached them will survive.

19 Apr 2013

Mental Health News and Research

Latest Mental Health News and Research

Viewpoints: Solving the doctor shortage; Can Gov. Scott convince Fla. lawmakers to accept Medicaid expansion?

Eating mushrooms can help increase, maintain vitamin D levels, find BUSM researchers

State roundup: Calif. lawmakers push for health plan for immigrants in U.S. illegally

New report presents recommendations to implement public health-based approach to drug policy

Alkermes reports topline results from phase 2 study of ALKS 5461 drug for major depressive disorder

Cerecor obtains exclusive, worldwide rights to NR2B receptor antagonist from Merck

First Edition: April 22, 2013

Advanced microscope reveals process where mutations lead to autism and other diseases

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

Study: Stem cell transplant heals neurological deficits in mice

Sleep related breathing disorders associated with cognitive and behavioral impairment in children

Study examines link between cognitive complaints and neuropsychological testing abnormalities in breast cancer patients

Viewpoints: A plan for cheaper, better care; The Philly abortion trial raises questions about regulations

Senate approves mental health amendment to 'effectively derailed' gun bill

Research shows early access to cognitive behavioural therapy can reduce risk of psychosis

Researchers examine health promotion and obesity prevention initiatives

First Edition: April 19, 2013

Targacept moving forward with Phase 2b study of TC-5619 for treatment of schizophrenia

Excess glutamate drives schizophrenia in high-risk individuals

Longer looks: The timely trauma response in Boston; Problems with aging doctors; Transplants from donors with HIV

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Mental Health News and Research

Latest Mental Health News and Research

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in